You are here: Industry Insights > Pfizer

News List

Pfizer's rejig made for growth, but it's also handy for a future split fiercepharma
August 01, 2018
Pfizer’s new three-unit structure may be all about driving growth for now, but don’t count out a long-awaited generics divestment down the line.
Pfizer's rejig made for growth, but it's also handy for a future split: executives fiercepharma
August 01, 2018
Pfizer’s new three-unit structure may be all about driving growth for now, but don’t count out a long-awaited generics divestment down the line.
Pfizer says shortage of adult-dose EpiPens in Canada will persist through August fiercepharma
August 01, 2018
Adult-dose EpiPens are once again in short supply in Canada as manufacturing issues persist at a Pfizer plant that produces them for Mylan.
Ups and Downs! Pain Medication Tanezumab of Pfizer/Eli Lilly to See the Dawn amid Twists and Turns? Mr. Nanguo
August 01, 2018
Pfizer and Eli Lilly jointly announced recently that the Phase III trial of their anti-NGF antibody: tanezumab for the treatment of osteoarthritis (OA) pain met all the 3 endpoints.
Pfizer drops diabetes and cancer drugs from clinical pipeline fiercebiotech
August 01, 2018
Pfizer has culled Type 1 diabetes and cancer drugs from its early-phase pipeline (PDF). The actions affect anti-IL7R antibody PF-06342674 and third-generation, mutant-selective EGFR tyrosine kinase inhibitor PF-06747775.
EC approves Pfizer's Herceptin biosimilar pharmatimes
August 01, 2018
Pfizer's Herceptin (trastuzumab) biosimlar Trazimera has been approved by the European Comission.
Nebraska lawmaker urges Pfizer to sue over use of its drugs in lethal injection procedure fiercepharma
July 31, 2018
Pfizer protested the use of its drugs in lethal injection procedures last year, asking states to return the drugs for a refund.
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive fiercepharma
July 31, 2018
Last year, Pfizer and Bristol-Myers Squibb’s Eliquis replaced Johnson & Johnson’s Xarelto as the leader of the novel oral anticoagulant class. And now it’s about to unseat an even bigger foe: warfarin.
Pfizer to build $465m injectable medicines facility in US pharmaceutical-technology
July 26, 2018
Pfizer has revealed plans to invest $465m for the construction of an advanced sterile injectable pharmaceutical manufacturing plant at Portage in Michigan, US.
Takeda's also-ran ALK drug Alunbrig aims to challenge Pfizer with new first-line data fiercepharma
July 26, 2018
Takeda's Alunbrig now sits in the back seat in ALK+ non-small cell lung cancer, behind rivals from Pfizer, Novartis and Roche. But the company has been pushing to change that, and on Wednesday, that effort got a leg up from new data.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page